Mr. Inas Said reports

RISE NANO OPTICS APPOINTS ERIK RITCHIE AS CHIEF COMMERCIAL OFFICER TO LEAD NORTH AMERICAN COMMERCIALIZATION STRATEGY

Rise Nano Optics Ltd. has appointed Erik Ritchie as chief commercial officer (CCO). Mr. Ritchie will lead Rise's North American commercialization strategy, overseeing go-to-market execution, operations, partnerships, and sales and marketing.

Mr. Ritchie brings deep executive leadership experience building and scaling global optical, e-commerce and consumer health businesses. He most recently served as chief executive officer of EnChroma, where he held full P&L (profit and loss) responsibility and led international expansion, new product development, operational optimization and profitability improvement across North America, Europe and Australia.

Previously, Mr. Ritchie served as chief commercial officer at Zenni Optical, one of the world's largest on-line prescription eyewear providers, where he led cross-functional teams spanning merchandising, marketing, UX/UI (user experience/user interface), customer service and technology, helping scale the platform to over 10 million customers globally.

"Erik's appointment marks a critical step as we move from product validation to commercial scale," said Inas Said, chief executive officer of Rise Nano Optics. "His experience leading organizations through high-growth phases and commercializing differentiated optical technologies makes him a strong addition to our executive team as we execute our North American launch."

As chief commercial officer, Mr. Ritchie will oversee North American operations, sales, marketing, strategic partnerships and channel development, supporting a phased commercialization strategy that includes optical labs and clinical partnerships, followed by broader consumer and brand integrations. He will also partner closely with product, operations and regulatory teams to support execution planning, organizational development and scalable market entry.

"I'm excited to join Rise at a pivotal inflection point," said Mr. Ritchie, CCO of Rise. "Rise has built a strong foundation in technology and IP [intellectual property], and my focus will be on translating that into a disciplined operating model -- aligning product, commercial execution and organizational capability to build a scalable North American business."

The appointment further strengthens Rise's executive leadership team as the company advances toward commercialization within the $160-billion (U.S.) global eyewear market.

Engagement of market making and investor relations

Rise also announces it has entered into a market-making agreement with Generation IACP Inc. (GIACP) to trade the common shares of the company with the objective of contributing to market liquidity. The services will be provided in compliance with the policies and guidelines of the Canadian Securities Exchange and applicable legislation.

Under the agreement dated March 9, 2026, GIACP will receive a fee of $8,500 plus applicable taxes per month. The initial term of the agreement is six months, and the agreement will automatically renew for additional six-month periods unless the company provides GIACP with written notice of termination at least 30 days prior to the end of the term or a renewal term.

GIACP is arm's length to the company and does not own any securities of Rise as of the date of this release; however, GIACP and its clients may acquire an interest in the securities of the company in the future.

GIACP will be responsible for the costs it incurs in buying and selling the company's shares, and no third party will be providing funds or securities for the market-making activities.

Rise has also engaged Strike Communications Inc. to provide capital markets and investor relations support, including investor awareness, corporate communications and social media. Strike is a boutique firm led by Julia Becker, which specializes in investor relations, marketing and corporate communications. Under the agreement dated March 15, 2026, Strike will receive a fee of $8,500 plus applicable taxes per month. The initial term of the agreement is 12 months, with written notice of termination at least 60 days prior to the end of the term.

Strike does not own any securities of Rise as of the date of this release; however, Strike and its principal may acquire an interest in the securities of the company in the future.

About Rise Nano Optics Ltd.

Rise Nano Optics trades on the Canadian Securities Exchange under the ticker symbol EYE. Rise is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented Spectraguard technology integrates nanomaterial innovation, ophthalmic research and scalable optical engineering to serve both clinical and consumer eyewear markets globally.

We seek Safe Harbor.